Investing.com - Medtronic (NYSE:MDT) reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Medtronic announced earnings per share of $1.13 on revenue of $7.37B. Analysts polled by Investing.com anticipated EPS of $1.12 on revenue of $7.22B.
Medtronic shares are down 10% from the beginning of the year and are trading at $93.09 , down-from-52-week-high.They are outperforming the S&P 500 which is down 13.18% from the start of the year.
Medtronic follows other major Healthcare sector earnings this month
Medtronic's report follows an earnings missed by Eli Lilly on Thursday, August 4, 2022, who reported EPS of $1.25 on revenue of $6.49B, compared to forecasts EPS of $1.7 on revenue of $6.85B.
Pfizer had beat expectations on Thursday, July 28, 2022 with second quarter EPS of $2.04 on revenue of $27.74B, compared to forecast for EPS of $1.72 on revenue of $25.49B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar